SARA MANCINI: Open Payments
NPI 1790972305 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,844 in 144 payments from 22 companies in 2025. Trend: 2023 $1,940 · 2024 $2,458 · 2025 $2,844
Food & beverage: $2,844
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 19 | $596 |
| ABBVIE INC. | 34 | $517 |
| Amgen Inc. | 15 | $222 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $203 |
| Janssen Biotech, Inc. | 8 | $191 |
| Novartis Pharmaceuticals Corporation | 9 | $167 |
| UCB, Inc. | 4 | $120 |
| Organon LLC | 11 | $117 |
| LEO Pharma Inc. | 5 | $104 |
| PFIZER INC. | 4 | $103 |
Products named: OPZELURA, SKYRIZI, OTEZLA, TREMFYA, RINVOQ, ILUMYA, Bimzelx, ANZUPGO.
Industry payments across PA — which companies pay providers there.
